Efficacy rate, toxicity rate, and hazard ratio for 2-dose and 3-dose scenariosa
Scenario . | 2-dose . | 3-dose . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 . | 1 . | 2 . | 0 . | 1 . | 2 . | 3 . | ||||||||||||
Dose . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . |
Efficacy rate | 0.20 | 0.20 | 0.40 | 0.40 | 0.22 | 0.40 | 0.20 | 0.20 | 0.20 | 0.39 | 0.40 | 0.41 | 0.20 | 0.40 | 0.40 | 0.20 | 0.26 | 0.40 |
Toxicity rate | 0.30 | 0.30 | 0.13 | 0.29 | 0.13 | 0.26 | 0.30 | 0.30 | 0.30 | 0.11 | 0.28 | 0.30 | 0.11 | 0.18 | 0.30 | 0.24 | 0.25 | 0.30 |
Hazard ratio | 1.00 | 1.00 | 0.64 | 0.64 | 0.97 | 0.64 | 1.00 | 1.00 | 1.00 | 0.64 | 0.63 | 0.62 | 0.95 | 0.64 | 0.62 | 0.96 | 0.79 | 0.64 |
Scenario . | 2-dose . | 3-dose . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 . | 1 . | 2 . | 0 . | 1 . | 2 . | 3 . | ||||||||||||
Dose . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . |
Efficacy rate | 0.20 | 0.20 | 0.40 | 0.40 | 0.22 | 0.40 | 0.20 | 0.20 | 0.20 | 0.39 | 0.40 | 0.41 | 0.20 | 0.40 | 0.40 | 0.20 | 0.26 | 0.40 |
Toxicity rate | 0.30 | 0.30 | 0.13 | 0.29 | 0.13 | 0.26 | 0.30 | 0.30 | 0.30 | 0.11 | 0.28 | 0.30 | 0.11 | 0.18 | 0.30 | 0.24 | 0.25 | 0.30 |
Hazard ratio | 1.00 | 1.00 | 0.64 | 0.64 | 0.97 | 0.64 | 1.00 | 1.00 | 1.00 | 0.64 | 0.63 | 0.62 | 0.95 | 0.64 | 0.62 | 0.96 | 0.79 | 0.64 |
Scenario 0 represents a null case where all doses are ineffective and thus has no optimal dose. In 2-dose scenarios, scenarios 1 and 2 represent the optimal doses are doses 1 and 2, respectively; and in 3-dose scenarios, scenarios 1-3 represent the optimal doses are doses 1-3, respectively. The optimal dose is indicated in boldface.
Efficacy rate, toxicity rate, and hazard ratio for 2-dose and 3-dose scenariosa
Scenario . | 2-dose . | 3-dose . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 . | 1 . | 2 . | 0 . | 1 . | 2 . | 3 . | ||||||||||||
Dose . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . |
Efficacy rate | 0.20 | 0.20 | 0.40 | 0.40 | 0.22 | 0.40 | 0.20 | 0.20 | 0.20 | 0.39 | 0.40 | 0.41 | 0.20 | 0.40 | 0.40 | 0.20 | 0.26 | 0.40 |
Toxicity rate | 0.30 | 0.30 | 0.13 | 0.29 | 0.13 | 0.26 | 0.30 | 0.30 | 0.30 | 0.11 | 0.28 | 0.30 | 0.11 | 0.18 | 0.30 | 0.24 | 0.25 | 0.30 |
Hazard ratio | 1.00 | 1.00 | 0.64 | 0.64 | 0.97 | 0.64 | 1.00 | 1.00 | 1.00 | 0.64 | 0.63 | 0.62 | 0.95 | 0.64 | 0.62 | 0.96 | 0.79 | 0.64 |
Scenario . | 2-dose . | 3-dose . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 . | 1 . | 2 . | 0 . | 1 . | 2 . | 3 . | ||||||||||||
Dose . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . | 1 . | 2 . | 3 . |
Efficacy rate | 0.20 | 0.20 | 0.40 | 0.40 | 0.22 | 0.40 | 0.20 | 0.20 | 0.20 | 0.39 | 0.40 | 0.41 | 0.20 | 0.40 | 0.40 | 0.20 | 0.26 | 0.40 |
Toxicity rate | 0.30 | 0.30 | 0.13 | 0.29 | 0.13 | 0.26 | 0.30 | 0.30 | 0.30 | 0.11 | 0.28 | 0.30 | 0.11 | 0.18 | 0.30 | 0.24 | 0.25 | 0.30 |
Hazard ratio | 1.00 | 1.00 | 0.64 | 0.64 | 0.97 | 0.64 | 1.00 | 1.00 | 1.00 | 0.64 | 0.63 | 0.62 | 0.95 | 0.64 | 0.62 | 0.96 | 0.79 | 0.64 |
Scenario 0 represents a null case where all doses are ineffective and thus has no optimal dose. In 2-dose scenarios, scenarios 1 and 2 represent the optimal doses are doses 1 and 2, respectively; and in 3-dose scenarios, scenarios 1-3 represent the optimal doses are doses 1-3, respectively. The optimal dose is indicated in boldface.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.